C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 295/135 (2006.01) A61K 31/496 (2006.01) A61K 31/5377 (2006.01) A61P 25/28 (2006.01) C07D 295/155 (2006.01) C07D 413/12 (2006.01)
Patent
CA 2359105
The present invention relates to pharmaceutically acceptable salts of the compound of formula (I) or solvates of said salt in which the compound of formula (I) is as the (R)-enantiomer, the (S)-enantiomer or the racemate, a process for their preparation, pharmaceutical formulations containing said therapeutically active compounds and to the use of said active compounds in therapy.
La présente invention concerne des sels pharmaceutiquement acceptables du composé correspondant à la formule (I) ou des solvates desdits sels, le composé de la formule (I) étant identique à l'énantiomère-(R), l'énantiomère-(S) ou le racémate. L'invention concerne également un processus de préparation, des formulations pharmaceutiques contenant lesdits composés thérapeutiquement actifs, ainsi que leur utilisation thérapeutique.
Berg Stefan
Sohn Daniel
Astrazeneca Ab
Fetherstonhaugh & Co.
LandOfFree
New morpholinobenzamide salts does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with New morpholinobenzamide salts, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and New morpholinobenzamide salts will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1542240